These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 66568)

  • 21. Quantitative analysis of phenylalanine metabolites in urine to detect heterozygotes of phenylketonuria.
    Olek K; Oyanagi K; Wardenbach P
    Humangenetik; 1974 Apr; 22(1):85-8. PubMed ID: 4837293
    [No Abstract]   [Full Text] [Related]  

  • 22. Intracellular concentrations of phenylalanine, tyrosine and alpha-aminobutyric acid in 13 homozygotes and 19 heterozygotes for phenylketonuria compared with 26 normals.
    Thalhammer O; Pollak A; Lubec G; Königshofer H
    J Inherit Metab Dis; 1981; 4(2):73-4. PubMed ID: 6790854
    [No Abstract]   [Full Text] [Related]  

  • 23. Dynamics of hyperphenylalaninemia and intellectual outcome in teenagers with phenylketonuria.
    Didycz B; Bik-Multanowski M
    Acta Biochim Pol; 2017; 64(3):527-531. PubMed ID: 28850634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the phenylalanine tolerance test in detection of heterozygote carriers of phenylketonuria gene].
    Bernat K
    Pol Tyg Lek; 1992 Mar 2-9; 47(9-10):219-21. PubMed ID: 1437822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterozygote detection in phenylketonuria. Measurement of discriminatory ability and interpretation of the phenylalanine loading test by determination of the heterozygote likelihood ratio.
    Westwood A; Raine DN
    J Med Genet; 1975 Dec; 12(4):327-33. PubMed ID: 1219115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative inability of mother and child to convert phenylalanine of tyrosine--a possible cause of nonspecific mental retardation.
    Fujimoto A; Crawford R; Bessman SP
    Biochem Med; 1979 Jun; 21(3):271-6. PubMed ID: 496920
    [No Abstract]   [Full Text] [Related]  

  • 27. Biopterin derivatives in normal and phenylketonuric patients after oral loads of L-phenylalanine, L-tyrosine, and L-tryptophan.
    Leeming RJ; Blair JA; Green A; Raine DN
    Arch Dis Child; 1976 Oct; 51(10):771-7. PubMed ID: 1008581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of heterozygotes for phenylketonuria by constant intravenous infusion of L-phenylalanine.
    Jagenburg R; Rödjer S
    Clin Chem; 1977 Sep; 23(9):1661-5. PubMed ID: 890910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gas-liquid chromatography of phenylalanine and its metabolites in serum and urine of various hyperphenylalaninemic subjects, their relatives, and controls.
    Kitagawa T; Smith BA; Brown ES
    Clin Chem; 1975 May; 21(6):735-40. PubMed ID: 1122617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of phenylalanine tolerance tests and EEG examination in patients under treatment for phenylketonuria.
    Rothová N; Simková M; Hyánek J; Karger P; Hoza J; Holub J; Matousová M; Kunová V; Viletová H
    Acta Univ Carol Med Monogr; 1977; ():65-9. PubMed ID: 615445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum tyrosine within the first hour after an oral load of phenylalanine.
    Güttler F; Hansen G
    Scand J Clin Lab Invest; 1977 Dec; 37(8):717-21. PubMed ID: 601515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of heterozygotes of typical phenylketonuria].
    Farriaux JP; Delabre M
    Arch Fr Pediatr; 1972 Apr; 29(4):365-72. PubMed ID: 5053206
    [No Abstract]   [Full Text] [Related]  

  • 33. Discriminant analysis for detection of phenylketonuric heterozygotes.
    Christian BG
    Soc Biol; 1971 Mar; 18(1):64-72. PubMed ID: 5580588
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of phenylketonuric heterozygotes.
    Jackson SH; Hanley WB; Gero T; Gosse GD
    Clin Chem; 1971 Jun; 17(6):538-43. PubMed ID: 5103385
    [No Abstract]   [Full Text] [Related]  

  • 35. New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction.
    Smith I; Clayton BE; Wolff OH
    Lancet; 1975 May; 1(7916):1108-11. PubMed ID: 49470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The offspring of a phenylketonuric couple.
    Ugarte M; Maties M; Ugarte JL
    J Ment Defic Res; 1980 Jun; 24(2):119-27. PubMed ID: 7411596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenylketonuria: variable phenotypic outcomes of the R261Q mutation and maternal PKU in the offspring of a healthy homozygote.
    Kleiman S; Vanagaite L; Bernstein J; Schwartz G; Brand N; Elitzur A; Woo SL; Shiloh Y
    J Med Genet; 1993 Apr; 30(4):284-8. PubMed ID: 8487271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma phenylalanine and tyrosine levels during the day in normal female controls and female obligate phenylketonuria heterozygotes.
    De Groot CJ; Hommes FA
    Enzyme; 1982; 28(4):404-7. PubMed ID: 7151779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamine depletion in phenylketonuria. A possible cause of the mental defect.
    Perry TL; Hansen S; Tischler B; Bunting R; Diamond S
    N Engl J Med; 1970 Apr; 282(14):761-6. PubMed ID: 5416968
    [No Abstract]   [Full Text] [Related]  

  • 40. [Intracellular concentration of phenylalanine, tyrosine and alpha-amino butyric acid in 13 homozygotes and 19 heterozygotes for phenylketonuria (PKU) compared with 26 normals (author's transl)].
    Thalhammer O; Pollak A; Lubec G; Königshofer H
    Klin Padiatr; 1980 Nov; 192(6):608-12. PubMed ID: 7194402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.